FWP

Filed pursuant to Rule 433

Issuer Free Writing Prospectus, dated October 7, 2014

Supplementing the Preliminary Prospectus Supplement, dated October 7, 2014

Registration No. 333-175791

HCA Inc.

$2,000,000,000

$600,000,000 4.25% Senior Secured Notes due 2019 (“2019 notes”)

$1,400,000,000 5.25% Senior Secured Notes due 2025 (“2025 notes”)

Pricing Supplement

Pricing Supplement dated October 7, 2014 to HCA Inc.’s Preliminary Prospectus Supplement dated October 7, 2014. This Pricing Supplement is qualified in its entirety by reference to the Preliminary Prospectus Supplement. The information in this Pricing Supplement supplements the Preliminary Prospectus Supplement and supersedes the information in the Preliminary Prospectus Supplement to the extent it is inconsistent with the information in the Preliminary Prospectus Supplement. Financial information present in the Preliminary Prospectus Supplement is deemed to have changed to the extent affected by changes described herein. Capitalized terms used in this Pricing Supplement but not defined have the meanings given them in the Preliminary Prospectus Supplement.

Change in Offering Size

The total size of the offering has been increased from $1,500,000,000 to $2,000,000,000. The net proceeds received from the increase of $500,000,000 will be used for general corporate purposes. Corresponding changes will be made where applicable throughout the Preliminary Prospectus Supplement.

Terms Applicable to the 2019 notes

 

Issuer    HCA Inc.
Aggregate Principal Amount    $600,000,000
Title of Security    4.25% Senior Secured Notes due 2019
Maturity    October 15, 2019
Spread to Treasury    263 basis points
Benchmark Treasury    UST 1.75% due September 30, 2019
Coupon    4.250%
Public Offering Price    100.000% plus accrued interest, if any, from October 17, 2014
Yield to Maturity    4.250%


Interest Payment Dates    April 15 and October 15 of each year, beginning on April 15, 2015
Record Dates    April 1 and October 1 of each year
Gross Proceeds    $600,000,000
Net Proceeds to Issuer before Expenses   

$594,000,000

CUSIP/ISIN Numbers   

CUSIP: 404119 BP3

ISIN: US404119BP36

Terms Applicable to the 2025 notes

 

Issuer    HCA Inc.
Aggregate Principal Amount    $1,400,000,000
Title of Security    5.25% Senior Secured Notes due 2025
Maturity    April 15, 2025
Spread to Treasury    291 basis points
Benchmark Treasury    2.375% due August 15, 2024
Coupon    5.250%
Public Offering Price    100.000% plus accrued interest, if any, from October 17, 2014
Yield to Maturity    5.250%
Interest Payment Dates    April 15 and October 15 of each year, beginning on April 15, 2015
Record Dates    April 1 and October 1 of each year
Gross Proceeds    $1,400,000,000
Net Proceeds to Issuer before Expenses   

$1,386,000,000

CUSIP/ISIN Numbers   

CUSIP: 404119 BQ1

ISIN: US404119BQ19

 

-2-


Terms Applicable to the 2019 notes and 2025 notes
Optional Redemption (Make Whole Call)   

Each series of notes will be redeemable, at our option, at any time in whole or from time to time in part, at a redemption, or “make-whole,” price equal to the greater of:

 

(i)     100% of the aggregate principal amount of the notes to be redeemed, and

 

(ii)    an amount equal to sum of the present value of the remaining scheduled payments of principal of and interest on the notes to be redeemed (excluding accrued and unpaid interest to the redemption date and subject to the right of Holders on the relevant record date to receive interest due on the relevant interest payment date) discounted from their scheduled date of payment to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate plus 50 basis points

 

plus, in each of the above cases, accrued and unpaid interest, if any, to such redemption date.

Change of Control    Upon certain change of control events, each Holder may require the Issuer to repurchase at 101%, plus accrued and unpaid interest, if any.
Trade Date    October 7, 2014
Settlement Date:   

October 17, 2014 (T+7)

 

We expect that delivery of the notes will be made to investors on or about October 17, 2014, which will be the seventh business day following the date of this pricing term sheet (such settlement being referred to as “T+7”). Under Rule 15c6-1 under the Exchange Act, trades in the secondary market are required to settle in three business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes prior to the delivery of the notes hereunder will be required, by virtue of the fact that the notes initially settle in T+7, to specify an alternate settlement arrangement at the time of any such trade to prevent a failed settlement. Purchasers of the notes who wish to trade the notes prior to their date of delivery hereunder should consult their advisors.

Use of Proceeds   

We estimate that our net proceeds from this offering, after deducting underwriter discounts and commissions and estimated offering expenses, will be approximately $1.978 billion.

 

We intend to use the net proceeds from the notes offered hereby to redeem all of our outstanding $1.400 billion 7 ¼% senior secured notes due 2020, to pay related fees and expenses and for general corporate purposes.

Denominations    $2,000 and integral multiples of $1,000
Form of Offering    SEC Registered (Registration No. 333-175791)
Joint Book-Running Managers   

Merrill Lynch, Pierce, Fenner & Smith Incorporated

Barclays Capital Inc.

Citigroup Global Markets Inc.

Credit Suisse Securities (USA) LLC

Deutsche Bank Securities Inc.

Goldman, Sachs & Co.

J.P. Morgan Securities LLC

Morgan Stanley & Co. LLC

RBC Capital Markets, LLC

SunTrust Robinson Humphrey, Inc.

UBS Securities LLC

Wells Fargo Securities, LLC

Co-Managers   

Credit Agricole Securities (USA) Inc.

Fifth Third Securities, Inc.

Mizuho Securities USA Inc.

SMBC Nikko Securities Americas, Inc.

 

-3-


The issuer has filed a registration statement (including a prospectus and a related preliminary prospectus supplement) with the United States Securities and Exchange Commission (“SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other documents HCA Holdings, Inc. has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus may be obtained by emailing Merrill Lynch, Pierce, Fenner & Smith Incorporated at dg.prospectus_requests@baml.com.

This communication should be read in conjunction with the preliminary prospectus supplement and the accompanying prospectus. The information in this communication supersedes the information in the preliminary prospectus supplement and the accompanying prospectus to the extent inconsistent with the information in such preliminary prospectus supplement and the accompanying prospectus.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

 

-4-